Sobre 1 señal de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the full record of transactions filed by Luly Jay R., Presidente y Director General. Officer active across 1 company, notably Enanta Pharmaceuticals INC. Aggregated, 22 reports have been logged. Split: 1 buy · 4 sells. Total volume traded: €634k. History available since 15 September 2021. The latest transaction was filed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Luly Jay R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4516 títulos@ 59,0562 US$10.3% de su flujoCommon StockSEC:0001177648-21-000025:0
22 de 22 declaraciones
About Luly Jay R.
Luly Jay R. is Président-Directeur Général, and is listed as President and CEO at Enanta Pharmaceuticals INC (XNAS). Across 22 filings, the sampled filings run from 2021-09-17 to 2026-02-13, with 247034 EUR of buys and 386997 EUR of sells, and the most frequent transaction nature is Attribution.